Preventing the Onset of Type 2 Diabetes
The Prevent Diabetes STAT: Screen, Test, Act–Today initiative and National Diabetes Prevention Program (NDPP) Lifestyle Change Programs are essential to stem the rising tide of diabetes.
New Heart Concerns for Existing Class of Type 2 Medications
An FDA Panel recommends new safety information on DPP-4 inhibitors Onglyza and Nesina. Sam Grossman reviews this news and how it may affect marketing and prescribing of the medications.
A New Long-Acting Insulin Option
Sanofi’s recently approved insulin, Toujeo, is 300u/ml and offers clinicians and people with diabetes who have glycemic control issues another long-acting insulin. Sam Grossman discusses some of the studies’ findings.
Cut Half the Calories from Your Rice
White, brown, and wild are all options most of us love. For some, rice can be the ultimate trigger food.
Magnesium and Diabetes
This blog will explore the ins and outs of magnesium. Why we need it, how much we need, foods high in magnesium, medications that affect magnesium status and what the research is showing about the relationship it has to diabetes. Â
Meet the Swiss Army Knife of Diabetes Meters
The Dario glucose meter provides high functionality and numerous features to help make the life of people with diabetes easier. Andrew Stivelman reviews this high tech device and app and offers instructions into how to use them.
Taking My Type 1 Experience and Educating Others
Mary Rechtoris talks about resisting the urge to scold people about their sometimes hurtful comments about diabetes and taking their lack of knowledge about the disease and educating them to provide them with a better understanding.
How to Choose the Right Eating Plan
Certified diabetes educator Amy Hess-Fischl offers some guidance in determining how to incorporate a healthier diet.
Understanding R, N, and Premixed Insulins
Certified diabetes educator Megan Day provides an overview of these types of insulin, mechanisms of action, and who are candidates for these medicines.
A New Treatment for Diabetic Retinopathy
The FDA recently approved Lucentis for use of diabetic retinopathy. Pharmacist and certified diabetes educator Sam Grossman talks about the clinical trial results for the new drug and considerations of how people with the complication may want to consider talking to their provider about it.
Children and Youth with Type 2 Diabetes
I have helped many children with diabetes over the span of my career. Incidence of type 2 diabetes among children is increasing with time.
Overcoming Medication Adherence Challenges
Diabetes educator Debbie Berg discusses some strategies to make it easier to keep up with your regular regimen of medicine.
5 Reasons to Keep Blood Glucose Under Control
Why is it important to keep your blood glucose under control? For one, it help reduce your chance for complications. Find out more.
Want to Keep Your Relationship Going Strong? Intimacy is Key
Obesity and dealing with negative body images can get in the way of creating intimacy between couples. Here are ways to create intimacy and keep a relationship going strong.
Afrezza: Will it revolutionize insulin therapy?
The FDA approved the inhaled insulin, Afrezza, last summer, and it will likely undergo a massive marketing campaign to providers and possibly to people with diabetes directly. Here is some important clinical trial information about the medicine and how it is indicated for use in patients.